Nigeria warns against Lenacapavir use in pregnancy amid HIV prevention rollout

ArchivedVerified|11 articles|8 sources|1 blocks

Detected: Updated: Analyzed:

Healthcare

Reported Facts

Observable data points shared across all narratives

•The Nigerian government announced the restriction on Lenacapavir use for pregnant women on March 24, 2026.
•Lenacapavir is being introduced in eight Nigerian states starting in March 2026.
•Nigeria is scheduled to receive 179,700 doses of Lenacapavir by 2028 through support from the Global Fund.
•The federal government allocated $346 million in funding for tuberculosis and HIV programs, including the new injection.
•The rollout began with an initial shipment of 52,000 doses arriving in Nigeria by late March 2026.

What Could Happen If...

▸If Nigeria expands Lenacapavir use to pregnant women after further safety studies pregnant women at risk of HIV could gain protection, potentially reducing mother-to-child transmission rates.

Key Actors

Countries

🌍African countries 🌍Nigeria

Instruments

📈Lenacapavir

Organizations

🏛Federal Government of Nigeria

Source Coverage

AFRICA

11 articles

More coverage on this story

Signals

Single-block coverage

Primary Sources (11)

AFRICABusiness Day (South Africa)LENIAS HWENDA | Drive to make HIV-prevention shot in SA could reshape industry AFRICAPremium Times (Nigeria)Nigeria to receive 179,700 doses of new HIV prevention drug by 2028 – Global Fund AFRICAVanguard (Nigeria)TB, HIV: FG unveils $346m funding push, new prevention injection AFRICAAllAfrica - Top

Nigeria's federal government has confirmed that the HIV prevention injection Lenacapavir will not be administered to pregnant women as it begins rollout in eight states. This measure aims to safeguard maternal and fetal health while expanding access to a drug expected to reduce HIV transmission significantly. Nigeria plans to receive 179,700 doses by 2028, supporting its target to end AIDS by 2030.